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Alterations in Hepatic High-Energy Metabolism in 
Galactosamine-induced Acute Hepatic 
Failure in Rabbits 
KENICHI UCHIDA 
The First Department of Surgery, Faculty of Medicine, Kyoto University 
(Director: Prof. Dr. TAKAYOSHI TOBE) 
Acute hepatic failure was induced in rabbits by an intravenous injection of galactosamine 
(4.25 mmoles/kg), with a mortality rate of 0%以 6hr, 9.5°/o at 12 hr, and 50%以 18hr. SGOT, 
SGPT, alkaline phosphatase, SOCT, and LDH elevated significantly after 12 hr. The hepatic 
energy charge, culculated as (ATP十0.5ADP)/(ATP+ADP十AMP),decreased markedly from 
0.885 of normal to 0.823 at 6 hr (p< 0.05), and to 0.809 at 18 hr (p< 0.001) in accordance with the 
decrease of ATP synthesis in liver mitochondria. The blood ketone body ratio (acetoacetate/{J-
hydroxybutyrate), reflecting mitochondrial free NAD+/NADH ratio, decreased from 0.783 of 
normal to 0.418 at 12 hr (p<0.001), and to 0.459 at 18 hr (p<0.01) concomitant with the decrease 
of total ketone body concentrations. 
Blood glucose level decreased gradually and hyperinsulinemia was noted after 12 and 18 hr. 
NEFA level decreased at 6 hr, but did not at 12 and 18 hr compared with controls. Total amino 
acids concentrations elevated significantly after 12 and 18 hr, especially alanine, praline, and 
AAA (phenylalanine and tyrosine). By contrast, BCAA (valine, isoleucine, and leucine) elevat-
ed slightly, resulting in the decrease of amino acid molar ratio (BCAA/AAA). The molar ratio 
was closely related to the hepatic energy charge (r=0.66, p<0.001). 
Hepatic energy charge was restored by an infusion of glucose solution at 6 hr, but decreased 
to 0.778 with hyperglycemia at 12 hr. 
Key words: Acute hepatic failure, Galactosamine、Livermitochondria, Energy metabolism, Blood ketone body 
ratio. 
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These results suggest that glucose is the substrate predominantly utilized in the early stage 
of acute hepatic failure, by contrast, whereas ,B-oxidation of fatty acids is predominant in the 
critical stage when blood ketone body ratio is below 0.5, due to inhibition of glucose utilization, 
and the inhibition ofβoxidation and ketogenesis in the later stage. In addition, abnormality 
of serum amino acids in acute hepatic failure is possibly due to the suppressed cataboli.sm of 






































Blitz紅白の方法に準じて Gal4.25 m mol/kgを5.sぢグ



















酸 Sm！及び EDTA1 mlを加えて homogenizeし，
とれを 04'C, 10, 000 g ICて15分遠沈した．その上清
を69,SぢK.co.にて pH6.0 IC調整後，再逮枕してその
上清を adeninenucleotidesの測定に用いた＂・
Energy Charge （以下 EC.）は次の公式によったU




















酸及びピルビン酸の測定の為IL，動脈血 2rnlIC 6% 
過塩素酸2mlを加えて覚はんし04'C, 10, 000 g にて
15分遠枕した．その上清を69%K2COaILて pH6.0 
IL調整後，再逮沈してその上清を測定に用いた．又，
動脈血2ml IL20~ぢズルホサリチル酸 0.5 mlを加えて
除蛋白した血清を材料として，島津高速液体クロマト
グラフ（LC4A型）を使用して18種類の血清遊離アミ
ノ酸濃度（Asp,Thr, Ser, Glut, Pro, Gly, Ala, Cys, 
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Fig, 1. Changes in the activities of SGOT, SGPT, Alkaline Phosphatase, SOCT and 
LDH after galactosarnine injection (rnean±S.E.). 
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Fig. 2. Changes in the concentrations of total bilirubin, ammonia, BUN, and crea-
tinine in arterial plasma after galactosamine injection (mean土S.E.i.
*pく0.01，材pく0.005, compared with the normal values. ・ 
Table l. Mortality 
Hr after i吋ection No of rabbits of dying (%) 
0 - 6 0/28 (0) 
12 2/21 (9.5) 
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Fig. 3. Changes in the values of serum albumin 
and hematocrit after galactosamine in jec-
tion (mean士S.E.).
下と比例して減少しているが， ADP量や AMP量は
対照群とほとんど差がなかった． ATP synthesized/mg protein/min）より39.8と低下し
分離肝Mtの酸化的燐酸化能はGal投与6時間後7 ており， Gal投与後早期より肝 Mtの機能が障害され
例のうち6例が uncouplingを呈し測定できなかった． ているととを示した．又， 12時間及び18時間後に採取
残る1例も呼吸調節能が正常レベル3.82土0.10より2. した分離肝 Mtはいずれも uncouplingを呈した．図
15へ， ATP生成能が正常レベル68.7士3.0 (n mol of 4で示すように肝 Mtの電子伝達系内の呼吸酵素チト
Table 2. Changes in the Concentrations of Adenine Nucleotides and the Energy Charge of Rabbit 
Livers after Galactosamine I吋ection
(μ, mol/g wet liver) 
Energy charge 
ATP ADP AMP Total 
Normal (15 ~~；｛~~t) (5) 4. 352土0.180 0. 887 ±0. 148 0. 145 ±0. 022 5. 384±0.172 0.885土0.009
After the i吋 on
6hr (7) 1. 897土0.222< 0.545土0.075b 0. 181 ±0. 018 2.624土0.290° 0.823土0.009•
control (4) 3.949士0.299 1. 037土0.123 0.293土0.064 5.097土0.028 0.868士0.012
12 hr (7) 2.035 土0.302• 0.665土0.057 0.134土0.014 2.834土0.356< 0.828土0.010•
control (4) 3.662土0.520 0.821土0.044 0.207土0.044 4.686士0.564 0. 871 ±0. 014 
18 hr (7) 1. 255土0.179< 0.474土0.058 0.105土0.017 1. 840±0. 230< 0. 809±0. 009< 
control (4) 3.898土0.286 0. 904±0. 042 0.170土0.028 4. 973±0. 323 0. 874土0.005
Results shown are mean values士S.E.with n values in parentheses. 
Total=ATP+ADP+AMP; energy charge=ATP+l/2ADP/ATP十ADP+AMP
•pく0.05, bpく0.01,"pく0.001,compared with the values in the control rabbits. 
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クローム a(+as）量は， 18時間後IL有意に減少した
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Fig. 4. Changes in the concentrations of cyto・
chrome a( +as) after galactosamine in-
jection (mean士S.E.).





(r=O. 59, pく0.001). ンスリン血症を呈した．
血糖値は Gal投与後早期より低下し，経過ととも 表5は Gal投与直後より50,)iぢ糖液を少量持続注入
に更に低値を示すようになった．血中インスリン値は し， 6時間及び12時間後の各 stageでの糖投与の効果
6時間後では正常レベルであったが， 12時間及び18時 を示したものである.Gal投与6時間後では，糖投与
間後では50μ,U/ml以上の高値を示した（pく0.005). 1とより肝 E c.は 0.877と正常レベルまで改善され
血中 NEFA値は6時間後lζ対照群より減少し（pく た．血中ケトン体比は2.167と急上昇し，ケトン体
0. 005), 12時間及び18時間後では対照群とほぼ閉じよ 総量も減少した．血糖値は糖液持続注入にもかかわら
うな値を示した（図7). ず 98mg/dlk維持された．一方， Gal投与12時間後
Table 3. Changes in the Concentrations of Ketone Bodies, Pyruvate, and Lactate in Arterial 
Blood after Galactosamine Injection 
(μ. mol/ml of whole blood) AcAc (μ, mol/ml of whole blood) 
AcAc B-OHB Total B-OHB Pyruvate Lactate 
Normal (15hr-f3:st) (5) 0. 059±0. 007 0. 097土0.0130.156土0.015 o. 783士0.072 0. 366土o.044 5. 990土0.436 
After the injection 
6 hr (7) 
Control (4) 
12 hr (7) 
Control (4) 
18 hr (7) 
Control (4) 
0. 068±0. 017 0. 122士0.031 0. 202±0. 045 o. 630±0. 098 0. 359土0.024 6. 080士0.787 
0.103±0. 046 0.122士0.0410.225土0.087 o. 780士0.135 0. 456士0.120 5.193±0. 758 
0. 072±0. 014 0.169土0.0230.241士0.036 0. 418±0. 030C 0. 255土0.031 7. 442士1.136• 
0.085土0.024 0.145土0.0290.230土0.103 0. 634±0. 048 0.181土0.043 3. 415士1.437 
0.034土o.004• 0. 075±0. 008 0.109土0.011 a 0. 459士o.028b 0. 376±0. 06110. 324士1.465• 
0.076土0.029 0.126±0. 053 o.202土0.059 0. 734土0.149 0. 233士0.086 4. 474士1.661 
Results shown are mean values土S.E.with n values in parentheses. 
AcAc=acetoacetate, B・OHB＝βhydroxybutyrate. 





















Table 4. Changes in the Concentrations of Ketone Bodies, Pyruvate, and Lactate in Rabbit 
Livers after Galactosamine Injection 
AcAc 




(JL mo!/ g wet liveの
Pyruvate Lactate 
Normal (15hr-fast) (5) 0. 256±0. 019 0. 358土0.034 0.614土0.046 o.756士0.075 0. 262 ±0. 025 2. 976土0.549
After the injection 
6 hr (6) 0. 057 ±0. 010 0. 090士0.030 0.147土0.040 0. 754±0.173 0. 438士0.057 4. 041土0.618
Control (4) 0.041土0.011 0.161士0.135 0. 202±0. 078 o.647土0.027 o. 271士0.0662.652土0.130 
12 hr (6) 0.182±0. 052 0. 306土o.115 0. 489 ± o.165 0. 680土0.045• o.193土o.028 4. 310士0.178b
Control (4) 0.173土0.051 0.174士0.042 o. 347 ±0. 093 0. 986土0.1190.159土0.0511. 695土0.490
18 hr (7) 0.043土0.011 0.097土0.010 0. 139±0. 019 0. 441士0.108• o.344士o.084 8. 646±1. 070• 
Control (4) 0. 051 ±0. 011 0. 108士0.058 0.159土0.070 0. 785土0.089 0. 384土0.1233.384士0.840
Results shown are mean土S.E.with n values in parentheses. 
AcAc=acetoacetate, B-OHB＝βhydroxy butyrate. 
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Fig. 6. Relationship between the ketone body 
ratios in the arterial blood and the live-r 
tissue. 
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口：Control ・： Galactosam1ne
Fig. 7. Changes in blood glucose, plasma insulin, and serum NEFA levels after gala-
ctosamine injection (mean土S.E.).
*pく0.01，帥pく0,005, compared with the control values. 
，・
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Table 5. Effects of Glucose Infusion on Hepatic Adenine Nucleotides, Ketone Body Concen-
trations in Arterial Blood, Pyruvate and Lactate Level, Blood Sugar Level, NEFA 
Level, and Plasma Insulin Level after Galactosamine Injection 
After ~he• 
injection 
(μ, mol/g wet liver) 
ADP AMP Total Pyruvate Lactate ATP 
E.C. 
(μ mol/ml of whole blood) 
6 hr (4) 1. 643土0.268 0. 365土0.025 0. 068土0.010 2. 076土0.305 0. 877土0.009 o.269土0.015 7. 787土0.140 
12 hr (4) 0. 773士0.087 0. 305土0.040 0.107土0.008 1.185士0.136 0. 778土0.001 0.184土0.039 7. 262士0.499
(μ mol/ml of whole blood) 




－一一一一一一 (mg/di) (μEq/L) 
B-OHB Blood Sugar NEFA 
6hr(4) 0.036士0.0010.034土0.012 0. 070土0.012 2. 167土0.866 98±5 420土99 89士13
12 hr (4) 0. 031土0.0010.050±0. 002 0. 081土0.001 0. 641 ±0. 048 587土162 425±5 250士12
Results shown are mean values±S.E. with n values in parentheses. 
E.C.=energy charge (ATP+l/2ADP/ATP+ADP十AMP）~ AcAc=acetoacetate; B-OHB=,8-hydro-
xybutyrate 
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Insulin ( .uU/m2) 
Fit. 8. Relationship between blood ketone body 
ratio and plasma insulin level, before and 
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口：Control•:Galactosamine 
Fig. 9. Changes in the concentrations of serum 
total amino acids and the amino a口dmolar 
ratios (Valine+ Isoleucine + Leucine; BCAA 
/Phenylalanine+ Tyrosine; AAA) after ga・
lactosamine injection (mean士S.E.).
*p<O. 001, compared with the control va・
lues. 
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Chane-es in the concentrations of serum 
bran品ed chain amino acids (BCAA); 
Valine, Is。leucine,and Leucine after ga・ 
lactosamine injection (mean土S.E.).
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口： Control•: Galactosamine 
Fig. 11. Changes in the concentrations of serum 
aromatic amino acids (AAA); Phenylal-
anine and Tyrosine after galactosamine 
injection (mean±S.E.). 








間後の早期より肝 E C はo.8231C低下し， 18時間後
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Fig. 13. Relationship between hepatic energy cha-
rge (ATP+0.5ADP/ATP+ADP+AMP) 
and amino acid molar ratio (Valine+ 
Isoleucine + Leucine/Phenylalanine +Tyro-
sine). 
Open circle; controls, Closed circle; re-
ceived galactosamine injection. 
Y=0.024X+O. 783, r=0.661, p<0.001 
になると肝 E c.は更に0.809まで低下し，死亡率も
増加した．全経過中，肝 E.C.の低下IC従って肝組織 接効果による可能性が強く， invivoでは E.C.の低下
中の ATP量は減少するにもかかわらず， ADP量や の度合から uncouplingしているとは考えられない．
AMP量は減少しておらず，肝 E c.の低下は主に しかし， Mt内の電子伝達系成分であるチトクローム
ATP量の減少によるものと考えられる．実際IC,in a( +a3）量も Gal投与18時間後には有意の減少をして
vitroの実験ではあるが， Gal投与後早期より分離肝 おり， Galが肝 Mtのどの部位に作用するのかは明ら
Mtの酸化的燐酸化能は障害されており 25，四‘又，正 かでないものの， Gal投与による肝 Mtの障害がATP
常家兎の分離肝MtへGalを添加する実験により，Gal 産生系の抑制をもたらし，肝 E.C.の低下せる主要な
によって直接的に Mtの酸化的燐酸化能が障害され 原因の一つであることが推察される．
た．しかしながら， Gal投与後の肝 Mtの酸化的燐酸 肝 Mtにおける ATP産生は電子伝達系における酸
化能の障害は， Mtの分離調整中に Mtと Galとの直 化的燐酸化によっているが，とれは Mt内の酸化還元
状態と密接に関連しており，実験的ICも黄痘肝や肝切
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